tb morbidity
play

TB Morbidity New Jersey, 2009 2018 450 400 405 405 350 300 - PowerPoint PPT Presentation

Dec 18, 2022 •411 likes •553 views

TB Morbidity New Jersey, 2009 2018 450 400 405 405 350 300 331 326 302 307 302 291 294 250 283 200 150 100 50 0 TB Morbidity by Race/Ethni city New Jersey, 2009 2018 200 150 100 50 Asian Black Hispanic White 0

  1. TB Morbidity New Jersey, 2009 – 2018 450 400 405 405 350 300 331 326 302 307 302 291 294 250 283 200 150 100 50 0

  2. TB Morbidity by Race/Ethni city New Jersey, 2009 – 2018 200 150 100 50 Asian Black Hispanic White 0 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 Asian 143 154 112 145 121 137 146 125 146 143 Hispanic 126 123 105 79 109 103 105 98 71 86 Black 89 86 71 47 55 43 48 49 42 44 White 44 41 43 31 34 24 27 22 24 18

  3. TB Morbidity by Country of Birth New Jersey, 2009 – 2018 450 400 350 302 310 300 302 TB Cases 249 250 253 266 251 200 253 237 248 150 100 50 102 95 82 66 60 60 56 49 46 43 0 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 US Born Foreign-Born

  4. TB Morbidity by Country of Birth New Jersey, 2018 (N=291) 15% 85% Foreign-born US Born

  5. TB Morbidity Cases/Case Rates* by County New Jersey, 2009 – 2018 County 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 Atlantic 14/5.2 12/4.4 8/2.9 9/3.3 10/3.6 9/3.2 13/4.7 5/1.8 6/2.2 1/.37 Bergen 37/4.0 43/4.8 29/3.2 38/4.2 37/3.9 29/3.1 35/3.7 30/3.2 14/1.4 35/3.7 Burlington 7/1.6 15/3.3 10/2.2 12/2.7 7/1.6 4/0.9 11/2.4 4/0.9 8/1.8 4/.90 Camden 15/2.9 10/1.9 12/2.3 10/2.0 15/2.9 11/2.1 11/2.2 12/2.3 10/2.2 11/2.2 Cape May 1/1.0 2/2.1 3/3.1 2/2.1 2/2.1 0/0.0 2/2.1 1/1.1 1/1.1 1/1.1 Cumberland 8/5.1 6/3.8 5/3.2 5/3.2 7/4.4 4/2.5 10/6.4 8/5.1 9/5.9 9/5.9 Essex 59/7.7 54/6.9 47/6.0 40/5.1 52/6.7 33/4.2 39/4.9 41/5.1 34/4.4 33/4.1 Gloucester 5/1.7 7/2.4 4/2.4 0/0.0 1/0.6 3/1.0 3/1.0 5/1.7 4/1.4 2/.68 Hudson 69/11.5 51/8.0 44/6.9 38/5.9 59/9.0 52/7.9 51/7.6 48/7.1 50/7.4 51/7.4 Hunterdon 2/1.5 2/1.6 2/1.6 0/0.0 1/1.0 0/0.0 4/3.2 0/0.0 4/3.2 2/1.6 Mercer 16/4.4 16/4.4 13/3.5 9/2.5 12/3.3 13/3.5 20/5.4 15/4.0 13/3.5 11/2.9 Middlesex 52/6.6 65/8.0 48/5.9 59/7.2 31/3.8 57/6.9 53/6.3 44/5.2 49/5.7 44/5.2 Monmouth 14/2.2 15/2.4 11/1.7 6/0.9 12/2.0 8/1.3 9/1.4 11/1.7 9/1.4 15/2.4 Morris 11/2.3 7/1.4 15/3.0 9/1.8 12/2.4 8/1.6 9/1.8 8/1.6 11/2.2 12/2.4 Ocean 9/1.6 17/2.9 15/2.6 7/1.2 8/1.4 18/3.1 9/1.5 9/1.5 11/1.7 3/.50 Passaic 28/5.7 32/6.4 24/4.8 20/4.0 25/5.2 21/4.2 11/2.2 18/3.5 19/3.7 19/3.7 Salem 3/4.5 2/3.0 0/0 1/1.5 0/0 1/1.5 2/3.1 0/0.0 0/0.0 1/1.6 Somerset 17/5.2 14/4.3 9/2.8 13/4.0 6/1.8 15/4.5 9/2.7 6/1.8 9/3.0 10/3.0 Sussex 2/1.3 1/0.7 1/0.7 2/1.3 3/2.0 0/0.0 0/0.0 1/0.7 0/0.0 0/0.0 Union 33/6.3 34/6.3 31/5.8 21/4.0 18/3.3 20/3.8 24/4.4 26/4.7 20/3.4 24/4.3 Warren 3/2.7 0/0.0 0/0.0 1/0.9 1/1.0 1/0.9 1/0.9 2/1.9 2/1.9 3/2.8 State Total 405/4.7 405/4.6 331/3.8 302/3.4 319/3.6 307/3.5 326/3.7 294/3.3 283/3.2 291/3.3 *Cases per 100,000 population Data Source: US Census Bureau Population estimates, July 1, 2017, (V2017)

  6. SUSSEX PASSAIC Passaic Counted TB Cases BERGEN WARREN New Jersey, 2014 – 2018 MORRIS ESSEX HUDSON UNION UNION SOMERSET SOMERSET HUNTERDON ≥200 MIDDLESEX 100 ─ 199 50 ─ 99 MONMOUTH MONMOUTH MERCER 20 ─ 49 < 20 OCEAN OCEAN BURLINGTON CAMDEN GLOUCESTER SALEM ATLANTIC CUMBERLAND CAPE CAPE MAY MAY

  7. TB Morbidity and Case Rates* Select Cities New Jersey, 2009 – 2018 City 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 Edison 10/10.0 15/15.0 11/11.0 16/15.9 8/7.9 10/9.8 11/10.8 7/6.8 10/9.8 6/5.9 Elizabeth 8/6.4 12/9.6 14/11.2 8/6.4 11/8.7 10/7.8 12/9.3 11/8.5 12/9.3 10/7.7 Jersey City 43/17.7 33/13.3 21/8.5 28/11.2 34/13.4 34/13.0 29/11.1 31/11.3 32/3.5 29/10.7 Newark 27/9.7 25/9.0 20/7.2 20/7.2 28/10.1 14/5.0 19/6.8 20/7.0 10/3.5 18/6.3 Paterson 15/10.3 12/8.2 12/8.2 12/8.2 5/3.4 12/8.2 6/4.1 1/0.7 12/8.2 5/3.4 *Cases per 100,000 population Data Source: US Census Bureau Population estimates, July 1, 2017, (V2017)

  8. TB Morbidity by Age Group New Jersey, 2009 – 2018 0 – 4 5 – 14 15 – 24 25 – 44 45 – 64 ≥ 65 200 150 100 50 0 Age 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 0 – 4 9 15 7 1 9 7 8 6 10 5 5 – 14 5 12 7 4 4 6 2 5 8 8 15 – 24 57 44 35 24 27 35 32 30 26 28 25 – 44 168 139 124 124 108 126 109 91 92 95 45 – 64 97 111 86 86 100 81 87 88 89 77 ≥ 65 69 84 72 64 71 52 88 74 58 78

  9. TB Morbidity in Health Care Workers New Jersey, 2009 – 2018 20 20 20 18 18 16 28 16 16 14 12 12 10 8 10 6 8 7 4 2 0 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018

  10. TB Morbidity in Health Care Workers New Jersey, 2009 – 2018 450 4.4% 4.9% 400 350 4.8% 2.1% 5.6% 6.5% 5.3% 4.1% 3.4% 300 2.8% TB Cases 250 200 150 100 50 0 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 All Other HC Workers

  11. TB/HIV Co-infection New Jersey, 2009 – 2018 30 25 27 26 25 20 23 15 17 15 16 15 14 10 10 5 0 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018

  12. TB/HIV Co-infection New Jersey, 2009 – 2018 450 7.2% 7.2% 400 350 7.3% 4.9% 7.5% 4.6% 5.6% 5.1% 3.4% 300 5.3% TB Cases 250 200 150 100 50 0 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 All other HIV Co-infection

  13. Multi-Drug Resistant TB by County New Jersey, 2009 – 2018 County 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 Atlantic 0 0 0 0 0 0 0 0 0 0 Bergen 2 1 0 1 1 1 0 0 0 0 Burlington 0 0 0 0 0 0 0 0 0 0 Camden 0 0 0 0 0 0 0 0 0 1 Cape May 0 0 0 0 0 0 0 0 0 0 Cumberland 0 0 0 0 0 0 0 0 0 0 Essex 0 4 1 1 0 0 1 0 0 1 Gloucester 0 0 0 0 0 0 0 0 0 0 Hudson 2 0 3 0 2 1 2 1 0 2 Hunterdon 0 0 0 0 0 0 0 0 0 0 Mercer 0 0 1 0 0 0 0 0 0 0 Middlesex 0 3 3 1 2 1 0 0 2 0 Monmouth 0 0 0 0 0 0 0 0 0 0 Morris 0 0 0 0 0 0 0 0 0 0 Ocean 0 0 0 0 0 1 0 1 1 0 Passaic 3 0 0 1 2 0 0 1 0 2 Salem 0 0 0 0 0 0 0 0 0 0 Somerset 1 0 0 0 0 0 0 0 0 0 Sussex 0 0 0 0 0 0 1 0 0 0 Union 1 0 0 0 0 0 0 0 0 1 Warren 0 0 0 0 0 0 0 0 0 0 State Total 9 8 8 4 5 4 4 3 3 7

Download Presentation
Download Policy: The content available on the website is offered to you 'AS IS' for your personal information and use only. It cannot be commercialized, licensed, or distributed on other websites without prior consent from the author. To download a presentation, simply click this link. If you encounter any difficulties during the download process, it's possible that the publisher has removed the file from their server.

Recommend

WITH CRONIC MORBIDITY - THE EFFECT OF INCOME: A COMPARATIVE STUDY OF CERTAIN CAUSES OF MORBIDITY

WITH CRONIC MORBIDITY - THE EFFECT OF INCOME: A COMPARATIVE STUDY OF CERTAIN CAUSES OF MORBIDITY

WITH CRONIC MORBIDITY - THE EFFECT OF INCOME: A COMPARATIVE STUDY OF CERTAIN CAUSES OF MORBIDITY IN BRAZIL AND THE US Kaiz Iwakami Beltro Sonoe Sugahara EBAPE/FGV, kaizo.beltrao@fgv.br ENCE/IBGE, sonoe.pinheiro@ibge.gov.br

898 views • 69 slides
Fu Hua Fu Hua Fudan University Fudan University 1 Morbidity and mortality of major cancers

Fu Hua Fu Hua Fudan University Fudan University 1 Morbidity and mortality of major cancers

Cancer Impact to Population Health and Responses in China Fu Hua Fu Hua Fudan University Fudan University 1 Morbidity and mortality of major cancers increase over the years (1998-2008) 1/100 000 Morbidity, Male Morbidity, Female

176 views • 17 slides
TB Morbidity New Jersey, 20082017 450 400 422 405 405 350 300 331 319 326 307 302

TB Morbidity New Jersey, 20082017 450 400 422 405 405 350 300 331 319 326 307 302

TB Morbidity New Jersey, 20082017 450 400 422 405 405 350 300 331 319 326 307 302 294 250 282 200 150 100 50 0 TB Morbidity by Race/Ethni city New Jersey, 20082017 200 150 100 50 Asian Black Hispanic White 0

175 views • 13 slides
Factors Factors of of Neonatal Neonatal Morbidity Morbidity at at the the Provincial

Factors Factors of of Neonatal Neonatal Morbidity Morbidity at at the the Provincial

Factors Factors of of Neonatal Neonatal Morbidity Morbidity at at the the Provincial Provincial Hospital Hospital Center of Center of Missour Missour Authors: Doukkali Loubna, MD, PhDs1 ; Bennani Mechita Nada2 ; Lahlou Laila2 ; Laamiri

195 views • 6 slides
TB Morbidity New Jersey, 2008 2017 450 400 422 405 405 350 300 331 319 326 307 302

TB Morbidity New Jersey, 2008 2017 450 400 422 405 405 350 300 331 319 326 307 302

TB Morbidity New Jersey, 2008 2017 450 400 422 405 405 350 300 331 319 326 307 302 294 250 283 200 150 100 50 0 TB Morbidity by Race/Ethni city New Jersey, 2008 2017 200 150 100 50 Asian Black Hispanic White 0

425 views • 13 slides
Registered morbidity and trend Registered morbidity and trend of infections diseases in of

Registered morbidity and trend Registered morbidity and trend of infections diseases in of

Registered morbidity and trend Registered morbidity and trend of infections diseases in of infections diseases in Mongolia Mongolia I. Respiratory infections Pertussis Diphtheria Rubella Erithema infectiosa

232 views • 21 slides
Maternal Morbidity: Neglected Dimension of Safe Motherhood Karen Hardee Jill Gay Ann Blan c

Maternal Morbidity: Neglected Dimension of Safe Motherhood Karen Hardee Jill Gay Ann Blan c

Maternal Morbidity: Neglected Dimension of Safe Motherhood Karen Hardee Jill Gay Ann Blan c Silent Suffering: Maternal Morbidities in Developing Countries Woodrow Wilson Center September 27, 2011 Outline Why Focus on Maternal Morbidity?

542 views • 32 slides
and Morbidity: The Role of Drug Overdoses Presentation to the House Select Committee on Opioids

and Morbidity: The Role of Drug Overdoses Presentation to the House Select Committee on Opioids

Maternal Mortality and Morbidity: The Role of Drug Overdoses Presentation to the House Select Committee on Opioids &amp; Substance Abuse Lisa Hollier, M.D., M.P.H Chair, Maternal Mortality and Morbidity Task Force Manda Hall, M.D. Associate

486 views • 23 slides
and Maternal Mortality Chris Glantz, MD, MPH Severe Maternal Morbidity (SMM) Severe/multisystem

and Maternal Mortality Chris Glantz, MD, MPH Severe Maternal Morbidity (SMM) Severe/multisystem

Severe Maternal Morbidity and Maternal Mortality Chris Glantz, MD, MPH Severe Maternal Morbidity (SMM) Severe/multisystem organ dysfunction or need for major intervention Defined by CDC as one or more of 18 conditions 1. Acute MI/aneurysm 10.

634 views • 29 slides
Maternal Mortality and Severe Morbidity in Arizona Attached to every statistic there is a

Maternal Mortality and Severe Morbidity in Arizona Attached to every statistic there is a

Maternal Mortality and Severe Morbidity in Arizona Attached to every statistic there is a person, family, child, or community. Dr. George Askew, MD, FAAP New York City Deputy Commissioner of Health Enid Quintana Torres, MPH Martn F.

664 views • 45 slides
1 Maternal Mortality and Severe Morbidity in Arizona Attached to every statistic there is a

1 Maternal Mortality and Severe Morbidity in Arizona Attached to every statistic there is a

1 Maternal Mortality and Severe Morbidity in Arizona Attached to every statistic there is a person, family, child, or community. Dr. George Askew, MD, FAAP New York City Deputy Commissioner of Health Enid Quintana Torres, MPH Martn

731 views • 47 slides
Major Causes of Morbidity and Mortality in SLE Patient EM EM, an 18-year-old Black female

Major Causes of Morbidity and Mortality in SLE Patient EM EM, an 18-year-old Black female

Major Causes of Morbidity and Mortality in SLE Patient EM EM, an 18-year-old Black female presents to the emergency department (ED) with acute onset of confusion and hallucinations Her parents report she has been complaining of

1.1k views • 65 slides
Major Causes of Morbidity and Mortality in SLE Patient EM EM, an 18-year-old Black female

Major Causes of Morbidity and Mortality in SLE Patient EM EM, an 18-year-old Black female

Major Causes of Morbidity and Mortality in SLE Patient EM EM, an 18-year-old Black female presents to the Emergency Department with acute onset of confusion and hallucinations Her parents report that she has been complaining of

682 views • 64 slides
Gastrointestinal haemorrhage A common emergency Important cause of mortality and morbidity

Gastrointestinal haemorrhage A common emergency Important cause of mortality and morbidity

Gastrointestinal haemorrhage A common emergency Important cause of mortality and morbidity Case fatality is high (10 20% in the UK) Rockall TA et al. BMJ, 1995. 311(6999): p. 222-6. Williams JG et al. Gut, 2007. 56 Suppl 1:

734 views • 14 slides
AND DIS-EASE (MORBIDITY) IN THE NEWBORN Balaji Govindaswami, MD, MPH Chief, Newborn Medicine,

AND DIS-EASE (MORBIDITY) IN THE NEWBORN Balaji Govindaswami, MD, MPH Chief, Newborn Medicine,

COMMON CAUSES OF DEATH (MORTALITY) AND DIS-EASE (MORBIDITY) IN THE NEWBORN Balaji Govindaswami, MD, MPH Chief, Newborn Medicine, SCVMC Director NICU and High Risk Follow-Up Clinical Professor (Affiliated) of Pediatrics Neonatal &amp;

597 views • 26 slides
Pneumococcal Disease: Morbidity and Mortality 1 Streptococcus pneumoniae (Pneumococcus)

Pneumococcal Disease: Morbidity and Mortality 1 Streptococcus pneumoniae (Pneumococcus)

Access additional quality improvement strategies by visiting the full toolkit here: www.achlcqicme.org/pneumonia/toolkit.apsx Pneumococcal Disease: Morbidity and Mortality 1 Streptococcus pneumoniae (Pneumococcus) Gram-positive bacteria

737 views • 27 slides
Florida, 2016 Tuberculosis Control Section Division of Disease Control and Health Protection

Florida, 2016 Tuberculosis Control Section Division of Disease Control and Health Protection

Tuberculosis Florida, 2016 Tuberculosis Control Section Division of Disease Control and Health Protection 4052 Bald Cypress Way, Bin A-20 Tallahassee, FL 32399 http://www.floridahealth.gov/diseases-and-conditions/tuberculosis Division of

491 views • 14 slides
Hepatoprotective Effect of Oligoribonucleotides-D-mannitol Complexes under Thioacetamide-induced

Hepatoprotective Effect of Oligoribonucleotides-D-mannitol Complexes under Thioacetamide-induced

Hepatoprotective Effect of Oligoribonucleotides-D-mannitol Complexes under Thioacetamide-induced Hepatotoxicity Tetiana Marchyshak 1 * , Igor Shmarakov 2 , Zenoviy Tkachuk 1 1 Institute of Molecular Biology and Genetics, National Academy of

362 views • 12 slides
A European Public-Private Partnership in Healthcare Michel Goldman, MD,PhD Executive

A European Public-Private Partnership in Healthcare Michel Goldman, MD,PhD Executive

A European Public-Private Partnership in Healthcare Michel Goldman, MD,PhD Executive Director ITMAT 2010, 27 October 2010 EFPIA Member Companies Participating companies (September 2010): Innovative Medicines Initiative: the Largest

503 views • 22 slides
Privacy in Machine Learning Fatemehsadat Mireshghallah WiMLDS NeurIPS19 Meet-up Why is privacy a

Privacy in Machine Learning Fatemehsadat Mireshghallah WiMLDS NeurIPS19 Meet-up Why is privacy a

Privacy in Machine Learning Fatemehsadat Mireshghallah WiMLDS NeurIPS19 Meet-up Why is privacy a concern in ML? Patient History Genetic Data Search History Famous incidents - Anonymization - A Face Is Exposed for AOL Searcher No.

1.51k views • 17 slides
Welcome to the HIV-TB Research Symposium MRC Clinical and

Welcome to the HIV-TB Research Symposium MRC Clinical and

Welcome to the HIV-TB Research Symposium MRC Clinical and Community HIV-TB Research Collaborating Centre Livingstone Hospital, 20 October 2017 Clinical &amp;

213 views • 7 slides
The Case for Common Goods for Health Welcome to this webinar session, we will be starting soon.

The Case for Common Goods for Health Welcome to this webinar session, we will be starting soon.

Webinar session - Building the Reset Series The Case for Common Goods for Health Welcome to this webinar session, we will be starting soon. Check the chat box for links and relevant information. Featuring: Agns Jesse B. Palitha Emmanuel

334 views • 8 slides
RESULTS United National Webinar Our Anti-Oppression Values 2 RESULTS is a movement of

RESULTS United National Webinar Our Anti-Oppression Values 2 RESULTS is a movement of

RESULTS United National Webinar Our Anti-Oppression Values 2 RESULTS is a movement of passionate, committed everyday people. Together we use our voices to influence political decisions that will bring an end to poverty. Poverty cannot end as

738 views • 50 slides
in Yorkshire and the Humber National Service Specification Gap Analysis Dr Alexis Gilbert

in Yorkshire and the Humber National Service Specification Gap Analysis Dr Alexis Gilbert

Commissioning of TB Services in Yorkshire and the Humber National Service Specification Gap Analysis Dr Alexis Gilbert Specialty Registrar in Public Health January 2017 National Strategy Areas for action (The Collaborative Tuberculosis

622 views • 20 slides

More recommend